These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22335076)

  • 21. Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington's Disease.
    Mullin AP; Corey D; Turner EC; Liwski R; Olson D; Burton J; Sivakumaran S; Hudson LD; Romero K; Stephenson DT; Larkindale J
    Clin Transl Sci; 2021 Jan; 14(1):214-221. PubMed ID: 32702147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The burden of rare diseases.
    Ferreira CR
    Am J Med Genet A; 2019 Jun; 179(6):885-892. PubMed ID: 30883013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Introduction and welcome message].
    Schwebig A; Levy N; Ayme S
    Presse Med; 2012 May; 41 Suppl 1():S1-2. PubMed ID: 22483772
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparing for the Future of Rare Diseases.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():641-648. PubMed ID: 29214596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with rare diseases work to jump-start research; advocacy groups create their own tissue banks to aid in drug treatment.
    Marcus AD
    Wall St J (East Ed); 2006 Jul; ():D1, D2. PubMed ID: 16906687
    [No Abstract]   [Full Text] [Related]  

  • 26. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Towards a better organisation of care for rare diseases in France : a ministry perspective].
    Chevrier A
    Med Sci (Paris); 2018 May; 34 Hors série n°1():9-10. PubMed ID: 29911544
    [No Abstract]   [Full Text] [Related]  

  • 28. Towards efficiency in rare disease research: what is distinctive and important?
    Jia J; Shi T
    Sci China Life Sci; 2017 Jul; 60(7):686-691. PubMed ID: 28639105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dealing with rare diseases in medicine and dermatology -- new developments].
    Bruckner-Tuderman L
    J Dtsch Dermatol Ges; 2014 Feb; 12(2):103-4. PubMed ID: 24494639
    [No Abstract]   [Full Text] [Related]  

  • 30. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 31. Antisense-mediated exon skipping: networking to meet opportunities and to overcome challenges.
    Aartsma-Rus A
    Nucleic Acid Ther; 2014 Feb; 24(1):1-3. PubMed ID: 24506778
    [No Abstract]   [Full Text] [Related]  

  • 32. How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient-physician interaction.
    Budych K; Helms TM; Schultz C
    Health Policy; 2012 May; 105(2-3):154-64. PubMed ID: 22464590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rare diseases. Foreword.
    Jones LH
    Future Med Chem; 2014 Jun; 6(9):969-70. PubMed ID: 25068979
    [No Abstract]   [Full Text] [Related]  

  • 34. National Organization for Rare Disorders (NORD): providing advocacy for people with rare disorders.
    Putkowski S
    NASN Sch Nurse; 2010 Jan; 25(1):38-41. PubMed ID: 20440954
    [No Abstract]   [Full Text] [Related]  

  • 35. [State of play of French data collections in the field of rare diseases].
    Aymé S
    Med Sci (Paris); 2018 May; 34 Hors série n°1():22-25. PubMed ID: 29911549
    [No Abstract]   [Full Text] [Related]  

  • 36. France. Cancer chief calls it quits after controversy.
    Enserink M
    Science; 2006 Aug; 313(5788):742. PubMed ID: 16902094
    [No Abstract]   [Full Text] [Related]  

  • 37. [Optimising treatment for people with rare diseases].
    Lund AM; Skovby F
    Ugeskr Laeger; 2006 Apr; 168(15):1547-50. PubMed ID: 16640978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solving for x: accelerators could speed search for rare disease therapies.
    Wolfson W
    Chem Biol; 2013 Dec; 20(12):1435-7. PubMed ID: 24359846
    [No Abstract]   [Full Text] [Related]  

  • 39. [Not Available].
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():29-33. PubMed ID: 27137859
    [No Abstract]   [Full Text] [Related]  

  • 40. France. Will French science swallow Zerhouni's strong medicine?
    Enserink M
    Science; 2008 Nov; 322(5906):1312. PubMed ID: 19039109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.